Evidence map›Paper›PMID 29023600›Full record

ArticlePLoS pathogens2017

Reduced accumulation of defective viral genomes contributes to severe outcome in influenza virus infected patients.

Jasmina Vasilijevic, Noelia Zamarreño, Juan Carlos Oliveros, Ariel Rodriguez-Frandsen, Guillermo Gómez, Guadalupe Rodriguez, Mercedes Pérez-Ruiz, Sonia Rey, Isabel Barba, Francisco Pozo and 3 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 106 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
106citing papers in PubMed, 2 pooled it
8.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

106 citing papers in PubMed, 2 syntheses or guidelines pooled it, 147 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Spatio-temporal modelling ofbioRxiv : the preprint server for biology · 2025
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

46 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Jasmina VasilijevicDepartment of Molecular and Cellular Biology, National Center for Biotechnology, Spanish National Research Council (CNB-CSIC), Madrid, Spain.ORCID http://orcid.org/0000-0003-1627-9379
Noelia ZamarreñoDepartment of Molecular and Cellular Biology, National Center for Biotechnology, Spanish National Research Council (CNB-CSIC), Madrid, Spain.
Juan Carlos OliverosBioinformatics for Genomics and Proteomics, National Center for Biotechnology, Spanish National Research Council (CNB-CSIC), Madrid, Spain.
Ariel Rodriguez-FrandsenDepartment of Molecular and Cellular Biology, National Center for Biotechnology, Spanish National Research Council (CNB-CSIC), Madrid, Spain.ORCID http://orcid.org/0000-0001-6850-5003
Guillermo GómezDepartment of Molecular and Cellular Biology, National Center for Biotechnology, Spanish National Research Council (CNB-CSIC), Madrid, Spain.ORCID http://orcid.org/0000-0002-4628-5991
Guadalupe RodriguezUniversity Hospital San Pedro de Alcantara, Cáceres, Spain.
Mercedes Pérez-RuizHospital Virgen de las Nieves, Granada, Spain.ORCID http://orcid.org/0000-0003-4640-3107
Sonia ReyMicrobiology Department, University Hospital of Vigo, Vigo, Spain.
Isabel BarbaMicrobiology Department, Complejo Hospitalario de Ciudad Real, Spain.
Francisco PozoNational Influenza Center, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain.ORCID http://orcid.org/0000-0003-1828-733X
Inmaculada CasasNational Influenza Center, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain.ORCID http://orcid.org/0000-0003-1840-1198
Amelia NietoDepartment of Molecular and Cellular Biology, National Center for Biotechnology, Spanish National Research Council (CNB-CSIC), Madrid, Spain.
Ana FalcónDepartment of Molecular and Cellular Biology, National Center for Biotechnology, Spanish National Research Council (CNB-CSIC), Madrid, Spain.ORCID http://orcid.org/0000-0003-2557-488X
Consejo Superior de Investigaciones Científicas · ESInstituto de Salud Carlos III · ESHospital General Universitario de Ciudad Real · ESHospital San Pedro de Alcántara · ESHospital Universitario Virgen de las Nieves · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Influenza A virus (IAV) infection can be severe or even lethal in toddlers, the elderly and patients with certain medical conditions. Infection of apparently healthy individuals nonetheless accounts for many severe disease cases and deaths, suggesting that viruses with increased pathogenicity co-circulate with pandemic or epidemic viruses. Looking for potential virulence factors, we have identified a polymerase PA D529N mutation detected in a fatal IAV case, whose introduction into two different recombinant virus backbones, led to reduced defective viral genomes (DVGs) production. This mutation conferred low induction of antiviral response in infected cells and increased pathogenesis in mice. To analyze the association between low DVGs production and pathogenesis in humans, we performed a genomic analysis of viruses isolated from a cohort of previously healthy individuals who suffered highly severe IAV infection requiring admission to Intensive Care Unit and patients with fatal outcome who additionally showed underlying medical conditions. These viruses were compared with those isolated from a cohort of mild IAV patients. Viruses with fewer DVGs accumulation were observed in patients with highly severe/fatal outcome than in those with mild disease, suggesting that low DVGs abundance constitutes a new virulence pathogenic marker in humans.

Indexed as

AdolescentAdultAnimalsChildChild, PreschoolFemaleGenome, ViralHumansInfluenza A Virus, H1N1 SubtypeInfluenza A Virus, H5N1 SubtypeInfluenza, HumanMaleMiceMiddle AgedOrthomyxoviridae InfectionsVirulence

Identifiers

PMID29023600
PMCPMC5638565
OpenAlexW2762066873

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.